Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

SCYNEXIS PE Ratio 2013-2020 | SCYX

Current and historical p/e ratio for SCYNEXIS (SCYX) from 2013 to 2020. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. SCYNEXIS PE ratio as of August 11, 2020 is 0.00.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
  
SCYNEXIS PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2020-08-11 6.83 0.00
2020-03-31 0.78 $-0.59 0.00
2019-12-31 0.91 $-0.98 0.00
2019-09-30 1.07 $-0.73 0.00
2019-06-30 1.31 $-0.57 0.00
2019-03-31 1.51 $-0.64 0.00
2018-12-31 0.48 $-0.30 0.00
2018-09-30 1.20 $-0.61 0.00
2018-06-30 1.64 $-0.93 0.00
2018-03-31 1.34 $-0.86 0.00
2017-12-31 2.32 $-0.99 0.00
2017-09-30 2.41 $-0.72 0.00
2017-06-30 1.79 $-0.89 0.00
2017-03-31 2.76 $-1.29 0.00
2016-12-31 3.19 $-1.56 0.00
2016-09-30 3.87 $-1.56 0.00
2016-06-30 2.17 $-1.68 0.00
2016-03-31 4.03 $-1.90 0.00
2015-12-31 6.21 $-2.13 0.00
2015-09-30 7.28 $-2.23 0.00
2015-06-30 8.79 $-2.08 0.00
2015-03-31 8.30 $-2.28 0.00
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.072B $0.000B
SCYNEXIS, Inc. is a pharmaceutical company. It is engaged in the discovery, development, and commercialization of anti-infectives to address unmet therapeutic needs. The Company is developing its lead product candidate, SCY-078, as an oral and intravenous (IV) drug for the treatment of serious and life-threatening invasive fungal infections in humans. It also provides contract research and development services. SCYNEXIS, Inc. is headquartered in Durham, North Carolina.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $74.564B 42.41
Takeda Pharmaceutical (TAK) Japan $58.294B 10.16
Astellas Pharma (ALPMY) Japan $29.965B 15.18
Eisai (ESALY) Japan $27.403B 23.16
UCB SA (UCBJF) Belgium $23.720B 0.00
Merck (MKGAF) Germany $17.131B 22.47
Catalent (CTLT) United States $13.151B 50.84
Grifols, S.A (GRFS) Spain $12.369B 15.12
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $11.140B 0.00
Neurocrine Biosciences (NBIX) United States $10.539B 40.80
Ono Pharmaceutical (OPHLF) Japan $9.254B 16.36
Ionis Pharmaceuticals (IONS) United States $7.463B 47.27
Orion OYJ (ORINY) Finland $7.077B 24.56
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $7.052B 0.00
STADA ARZNEIMI (STDAF) Germany $6.858B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.803B 11.25
United Therapeutics (UTHR) United States $4.848B 11.21
Arrowhead Pharmaceuticals (ARWR) United States $4.151B 0.00
Evotec AG (EVTCY) Germany $4.113B 110.84
FibroGen (FGEN) United States $4.069B 0.00
Hypermarcas (HYPMY) Brazil $3.887B 14.30
ChemoCentryx (CCXI) United States $3.697B 0.00
Nektar Therapeutics (NKTR) United States $3.650B 0.00
PTC Therapeutics (PTCT) United States $3.250B 0.00
Sage Therapeutics (SAGE) United States $2.670B 0.00
Pacira BioSciences (PCRX) United States $2.563B 67.37
Taro Pharmaceutical Industries (TARO) Israel $2.442B 11.82
Cronos Group (CRON) Canada $1.942B 0.00
Revolution Medicines (RVMD) United States $1.848B 0.00
Xencor (XNCR) United States $1.832B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.765B 0.00
USANA Health Sciences (USNA) United States $1.741B 16.40
Indivior (INVVY) United States $1.614B 20.00
Ironwood Pharmaceuticals (IRWD) United States $1.583B 11.03
Corcept Therapeutics (CORT) United States $1.561B 14.37
Akebia Therapeutics (AKBA) United States $1.473B 0.00
Heron Therapeutics (HRTX) United States $1.413B 0.00
Zogenix (ZGNX) United States $1.372B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.264B 12.06
VAXART, INC (VXRT) United States $1.174B 0.00
CLINIGEN GP (CLIGF) United Kingdom $1.102B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.090B 0.00
Karyopharm Therapeutics (KPTI) United States $1.078B 0.00
Translate Bio (TBIO) United States $1.056B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.951B 592.13
Esperion Therapeutics (ESPR) United States $0.932B 0.00
Tilray (TLRY) Canada $0.865B 0.00
Altimmune (ALT) United States $0.739B 0.00
Vectura Group (VEGPF) United Kingdom $0.737B 0.00
Endo (ENDP) Ireland $0.729B 1.08
Trillium Therapeutics (TRIL) Canada $0.705B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.699B 0.00
ImmunoGen (IMGN) United States $0.672B 0.00
Collegium Pharmaceutical (COLL) United States $0.653B 0.00
Molecular Templates (MTEM) United States $0.599B 0.00
Flexion Therapeutics (FLXN) United States $0.597B 0.00
Radius Health (RDUS) United States $0.574B 0.00
Aerie Pharmaceuticals (AERI) United States $0.572B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.569B 0.00
Siga Technologies (SIGA) United States $0.554B 59.08
Crinetics Pharmaceuticals (CRNX) United States $0.516B 0.00
Ocular Therapeutix (OCUL) United States $0.510B 0.00
Innate Pharma SA (IPHYF) France $0.506B 0.00
Ardelyx (ARDX) United States $0.497B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.468B 23.36
DURECT (DRRX) United States $0.461B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.429B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.429B 0.00
Organogenesis Holdings (ORGO) United States $0.427B 0.00
TherapeuticsMD (TXMD) United States $0.422B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.346B 8.56
Harpoon Therapeutics (HARP) United States $0.344B 0.00
IMV INC (IMV) Canada $0.335B 0.00
Redhill Biopharma (RDHL) Israel $0.316B 0.00
Heat Biologics (HTBX) United States $0.316B 0.00
Concert Pharmaceuticals (CNCE) United States $0.299B 0.00
OptiNose (OPTN) United States $0.298B 0.00
MEI Pharma (MEIP) United States $0.296B 0.00
Calithera Biosciences (CALA) United States $0.293B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.290B 0.00
Rafael Holdings (RFL) United States $0.285B 0.00
PROFOUND MEDICL (PROF) Canada $0.279B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.275B 0.00
Lannett Co Inc (LCI) United States $0.249B 5.45
CASI Pharmaceuticals (CASI) United States $0.240B 0.00
Aquestive Therapeutics (AQST) United States $0.222B 0.00
Nature's Sunshine Products (NATR) United States $0.216B 21.33
KalVista Pharmaceuticals (KALV) United States $0.204B 0.00
Taiwan Liposome (TLC) Taiwan $0.194B 0.00
Nivalis Therapeutics (ALPN) United States $0.189B 0.00
Onconova Therapeutics (ONTX) United States $0.186B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.170B 0.00
Jounce Therapeutics (JNCE) United States $0.163B 7.69
Xeris Pharmaceuticals (XERS) United States $0.124B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.122B 0.00
Champions Oncology (CSBR) United States $0.117B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.114B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.110B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
Otonomy (OTIC) United States $0.103B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.102B 0.00
Lipocine (LPCN) United States $0.102B 0.00
Biomerica (BMRA) United States $0.101B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.098B 0.00
MediWound (MDWD) Israel $0.097B 0.00
Aclaris Therapeutics (ACRS) United States $0.097B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.094B 0.00
CTI BioPharma (CTIC) United States $0.094B 0.00
Hemispherx BioPharma (AIM) United States $0.090B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.090B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.084B 0.00
Addex Therapeutics (ADXN) Switzerland $0.079B 0.00
ElectroCore (ECOR) United States $0.076B 0.00
Recro Pharma (REPH) United States $0.076B 0.00
Infinity Pharmaceuticals (INFI) United States $0.069B 0.00
CV Sciences (CVSI) United States $0.067B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.065B 0.00
GTx (ONCT) United States $0.060B 0.00
Sundial Growers (SNDL) Canada $0.058B 0.00
PolarityTE (PTE) United States $0.056B 0.00
RENEURON GP (RNUGF) United Kingdom $0.053B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.051B 30.73
Novan (NOVN) United States $0.049B 0.00
AgeX Therapeutics (AGE) United States $0.049B 0.00
Natural Alternatives (NAII) United States $0.047B 0.00
IsoRay (ISR) United States $0.046B 0.00
Forward Pharma (FWP) Denmark $0.044B 0.00
Jaguar Animal Health (JAGX) United States $0.043B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.043B 0.00
Mannatechorporated (MTEX) United States $0.042B 9.36
Opiant Pharmaceuticals (OPNT) United States $0.039B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.036B 0.00
Neos Therapeutics (NEOS) United States $0.035B 0.00
Can-Fite Biopharma (CANF) Israel $0.033B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.031B 0.00
ProPhase Labs (PRPH) United States $0.030B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.030B 0.00
India Globalization Capital (IGC) United States $0.026B 0.00
Vical (BBI) United States $0.022B 0.00
Iterum Therapeutics (ITRM) Ireland $0.021B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.019B 0.00
Bio-Path Holdings (BPTH) United States $0.018B 0.00
RXi Pharmaceuticals (PHIO) United States $0.016B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.016B 0.00
Flex Pharma (SLRX) United States $0.015B 0.00
Regulus Therapeutics (RGLS) United States $0.015B 0.00
Cyanotech (CYAN) United States $0.014B 21.36
Shineco (TYHT) China $0.014B 0.00
China SXT Pharmaceuticals (SXTC) China $0.013B 0.00
Midatech Pharma (MTP) United Kingdom $0.013B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.012B 0.00
HANCOCK JAFFE (HJLI) United States $0.009B 0.00
Xenetic Biosciences (XBIO) United States $0.008B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00